Cargando…

Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report

Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghimi, Minoo, Nekoukar, Zahra, Gholami, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667295/
https://www.ncbi.nlm.nih.gov/pubmed/34938547
http://dx.doi.org/10.1002/ccr3.5161
_version_ 1784614365667786752
author Moghimi, Minoo
Nekoukar, Zahra
Gholami, Farhad
author_facet Moghimi, Minoo
Nekoukar, Zahra
Gholami, Farhad
author_sort Moghimi, Minoo
collection PubMed
description Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before.
format Online
Article
Text
id pubmed-8667295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86672952021-12-21 Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report Moghimi, Minoo Nekoukar, Zahra Gholami, Farhad Clin Case Rep Case Report Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before. John Wiley and Sons Inc. 2021-12-13 /pmc/articles/PMC8667295/ /pubmed/34938547 http://dx.doi.org/10.1002/ccr3.5161 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Moghimi, Minoo
Nekoukar, Zahra
Gholami, Farhad
Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_full Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_fullStr Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_full_unstemmed Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_short Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_sort mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667295/
https://www.ncbi.nlm.nih.gov/pubmed/34938547
http://dx.doi.org/10.1002/ccr3.5161
work_keys_str_mv AT moghimiminoo mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport
AT nekoukarzahra mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport
AT gholamifarhad mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport